Probiodrug is a privately held biopharmaceutical company focused on the development of innovative small molecule drugs. The Company was founded in 1997 and has raised a total of $52 million in private equity. In addition, it has generated more than...

Founded in 1997
Total money raised: $74.3M

06120 Weinbergweg 22


Phone: +49 345 5559900

Updated on Jan 4, 2012
Probiodrug at CrunchBase
Konrad Glund CEO
Hans-Ulrich Demuth CSO
Hendrik Liebers CFO
Jörg Neermann Board member
Dr. Axel Polack Board Director
Olivier Litzka Board Member
Kumar Srinivasan Chief business officer

January, 2012

Probiodrug raised $20.3M in unattributed round from BB Biotech Ventures, Edmond de Rothschild Investment Partners, Life Sciences Partners, Biogen Idec New Ventures, TVM Capital, and HBM BioVentures

Probiodrug Raises €15M in Funding

November, 2009

Probiodrug raised $54M in a Series B round from BB Biotech Ventures, Edmond de Rothschild Venture Capital, Biogen Idec New Ventures, IBG Fonds, TVM Capital, HBM BioVentures, CFH, and Life Sciences Partners

Probiodrug Closes Series B Financing Round exceeding EUR 36 Million (US$54 Million)


Probiodrug was founded in 1997